Neutral Transaction Layer for Healthcare
Foundation Health
Vendor neutrality makes Foundation easier to buy for healthcare companies that do not want their patient flow locked inside one pharmacy or lab. In practice, a customer can use Foundation to route prescriptions, benefits checks, prior authorizations, test orders, and lab results across a network of outside providers through one API layer. That turns Foundation into the control plane sitting between patient demand and fragmented healthcare supply, while avoiding the cost of owning the underlying clinical assets.
-
The product is built around orchestration, not ownership. Foundation exposes APIs for telehealth, pharmacy, and diagnostics, then passes only the required data to approved partners. That means a weight loss brand or health system can swap for price, geography, or service level without rebuilding its front end or care workflow.
-
Vertically integrated rivals make money by steering volume into their own assets. LetsGetChecked now combines home testing with an affiliate pharmacy and completed its Truepill acquisition on October 1, 2024, while Wheel bundles a 50 state clinician network and 70 plus care programs inside its Horizon platform. Those models can capture more economics per patient, but they give customers less supplier flexibility.
-
The tradeoff is that neutrality broadens distribution but shifts risk upstream. Foundation can serve health plans, manufacturers, and digital health brands that each want different pharmacy or diagnostic mixes, but its service quality depends on keeping enough third party capacity in network. As volume grows, the advantage comes from better routing, better automation, and denser coverage rather than from filling scripts in a captive pharmacy.
This model points toward Foundation becoming the neutral transaction layer for digital care, similar to how payments companies sit between merchants and banks. If it keeps adding provider density and automating more of the messy work around benefits, lab routing, and refill operations, the company can become harder to replace even without owning a single pharmacy or lab.